Molnupiravir; an effective drug in treating COVID-19?
Guardado en:
Autores principales: | Alireza Pouramini, Fatemeh Kafi, Shakiba Hassanzadeh, Sanam Saeifar, Hamid Reza Jahantigh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Diabetic Nephropathy Prevention
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92a7f207b4c645219bd978ee88a45ac2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molnupiravir—A Novel Oral Anti-SARS-CoV-2 Agent
por: Ching-Chi Lee, et al.
Publicado: (2021) -
Origins and Evolution of the Global RNA Virome
por: Yuri I. Wolf, et al.
Publicado: (2018) -
Reply to Holmes and Duchêne, “Can Sequence Phylogenies Safely Infer the Origin of the Global Virome?”: Deep Phylogenetic Analysis of RNA Viruses Is Highly Challenging but Not Meaningless
por: Yuri I. Wolf, et al.
Publicado: (2019) -
Top Three Strategies of ss(+)RNA Plant Viruses: Great Opportunists and Ecosystem Tuners with a Small Genome
por: Volodymyr V. Oberemok, et al.
Publicado: (2021) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Maria L. Agostini, et al.
Publicado: (2018)